LPL Financial
DMK

LPL Financial’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

LPL Financial’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-169
Closed -$9K – 3887
2020
Q3 		$9K Hold
169
– – ﹤0.01% 3536
2020
Q2 		$6K Sell
169
-43
-20% -$1.47K ﹤0.01% 3454
2020
Q1 		$5K Buy
212
+1
+0.5% +$42 ﹤0.01% 3198
2019
Q4 		$10K Buy
211
+11
+6% +$533 ﹤0.01% 3335
2019
Q3 		$10K Hold
200
– – ﹤0.01% 3277
2019
Q2 		$18K Hold
200
– – ﹤0.01% 3255
2019
Q1 		$30K Sell
200
-21
-10% -$4.06K ﹤0.01% 3146
2018
Q4 		$35K Sell
221
-102
-32% -$19.6K ﹤0.01% 3019
2018
Q3 		$79K Buy
323
+15
+5% +$3.55K ﹤0.01% 3142
2018
Q2 		$69K Hold
308
– – ﹤0.01% 3129
2018
Q1 		$76K Buy
308
+140
+83% +$36.7K ﹤0.01% 3097
2017
Q4 		$52K Sell
168
-17
-9% -$5.59K ﹤0.01% 2971
2017
Q3 		$68K Sell
185
-33
-15% -$11.7K ﹤0.01% 2806
2017
Q2 		$79K Buy
+218
New +$65.3K ﹤0.01% 2732

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial's DMK Position: Q4 2020 in Review

LPL Financial sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2020, closing a stake of 169 shares — an estimated $9K sold.

LPL Financial first reported a position in DMK in Q2 2017 and held it in 14 quarters. The position peaked at $79K in Q3 2018. 41 funds tracked by Wall St. Rank hold DMK as of Q4 2020.

  • LPL Financial reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2020 after selling out during the quarter.
  • LPL Financial sold 169 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2020, an estimated $9K.
  • LPL Financial first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2017 and held it in 14 quarters.
  • LPL Financial's DMK Pharmaceuticals Corporation Common Stock position peaked at $79K in Q3 2018.
  • 41 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2020.

Based on LPL Financial's 13F filing for Q4 2020, filed 12 Feb 2021.